CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells With or Without NKTR-255 in Adults With Recurrent or Refractory B Cell Malignancies
Clinical trial NCT03233854 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03233854
- Sponsor
- Stanford University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-01
- Primary completion
- 2023-06-20
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.